sublingual tirzepatide study on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Is sublingual delivery the future

We identified a lead candidate, azaA8 (Ala8aza-Ala in an Arg34-GLP-1 background), that resists DPP-4 degradation, retains low-picomolar receptor agonist potency, and produces significant metabolic benefits in both lean and diet-induced obese mice

Role of the brain melanocortins in blood pressure regulation

J Clin Invest 1983;71(4):91625

Can You Take Semaglutide with Underactive Thyroid

All three GLP-1 analogs exhibited good efficacy in glycemic control

Separately, the Medicare GLP-1 Bridge (launching July 1, 2026, running through December 31, 2027) provides weight-loss access to Wegovy at a fixed $50 per month copay outside the Part D benefit meaning the $50 does not count toward the deductible, TrOOP, or the $2,100 cap, and Extra Help cannot be applied